Companies: 10,795·Total market cap: $144.5T
HCW Biologics Inc.

HCW Biologics Inc.

HCWBNASDAQHealthcare● Active
$1.45
$-0.18(-11.04%)
Market Cap$3024477
P/E Ratio
52W High$7.35
52W Low$0.25

HCW Biologics Inc.(HCWB)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HCWB · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.05M$2.57M$2.84M$6.72M$0.00M
Cost of Revenue$0.04M$1.61M$2.28M$4.14M$0.00M
Gross Profit$0.01M$0.96M$0.56M$2.59M$0.00M
Gross Margin %(computed)20.00%37.38%19.72%38.48%
Operating Expenses
R&D Expenses$5.44M$6.39M$7.68M$9.34M$8.17M
G&A Expenses$7.70M$21.95M$13.08M$7.99M$4.98M
Total Operating Expenses$11.27M$30.44M$26.28M$17.67M$13.37M
Operating Income($11.26M)($29.48M)($25.72M)($15.08M)($13.37M)
Operating Margin %(computed)-904.96%-224.32%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.51M
Interest Expense$1.25M$1.16M$0.28M$0.13M$0.00M
Income Before Tax($7.96M)($30.02M)($24.99M)($14.90M)($12.86M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($7.96M)($30.02M)($24.99M)($14.90M)($12.86M)
Net Margin %(computed)-879.52%-221.67%
Per Share & EBITDA
EPS (Basic)$-10.63$-0.77$-0.70$-0.42$-0.36
Wtd Avg Shares2.10M38.79M35.93M35.82M35.77M
EBITDA($5.67M)($27.68M)($23.58M)($14.06M)($12.32M)
EBITDA Margin %(computed)-829.62%-209.10%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解HCW Biologics Inc.

关于HCW Biologics Inc.(HCWB)损益表

HCW Biologics Inc.(HCWB)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,HCWB实现营收$0.00B,毛利润$0.00B(毛利率20.00%),净利润($0.01B)(净利率-14677.14%)。

常见问题

HCWB · 4 问

HCW Biologics Inc.(HCWB)2025财年营收为$0.00B,同比down97.9%。

HCWB revenueHCWB salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08